FDA wants to help unproductive drugmakers
Given the rapid pace of scientific advances in medicine, you might think Big Pharma is in rude health. You would be wrong. Last year consultants at Deloitte estimated that returns [...]
Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry
With increasing frequency, generic drug manufacturers in the United States are able to challenge the monopoly status of patent-protected drugs even before their patents expire. The legal foundation for these [...]
Innovating Copyright
For those of us who have been blessed with an understanding of this regulation we call copyright, the lawyers representing the Mitchell estate were uttering something completely understandable.A sequel is [...]
Indirect Liability for Copyright Infringement: An Economic Perspective
When individuals infringe copyright, they often use tools, services, and venues provided by other parties. An enduring legal question asks to what extent those other parties should be held liable [...]